Allergy and Immunology, Allergy · Pinellas Park, FL
NPI
1679752760
Since 2007
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6233 66th St N
Pinellas Park, FL, 33781
Phone (727) 544-8100
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
3,826 services
Medicare patients, 2024
65
Average age 71
Drug cost, 2024
$1.8M
426 prescriptions
Company payments, 2025
$1,339
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madhurima Sanka was code 95004 (test - miscellaneous), 964 times for 17 patients. In total Madhurima Sanka billed 3,826 services in 18 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 964 | 17 | $2.63 | $2,535 |
| 95024 Test - Miscellaneous | Office | 339 | 15 | $5.96 | $2,021 |
| 99214 Office E&M - Established | Office | 51 | 25 | $91.32 | $4,658 |
| 99213 Office E&M - Established | Office | 36 | 30 | $66.51 | $2,394 |
| 99204 Office E&M - New | Office | 31 | 31 | $108.78 | $3,372 |
| 94060 Pulmonary Function Testing | Office | 25 | 18 | $29.30 | $733 |
| 96160 E&M - Miscellaneous | Office | 21 | 15 | $2.21 | $46.38 |
By year: 2022 $50K for 3,850 services; 2023 $52K for 2,679 services; 2024 $82K for 3,826 services.
Medicare prescription drug claims, 2024
In 2024, the drug Madhurima Sanka prescribed most often to Medicare patients was Montelukast Sodium, with 57 prescriptions and refills. In total Madhurima Sanka wrote 426 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 57 | 97 | 21 | $508 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 36 | 36 | 20 | $629 |
| Azelastine Hcl Generic | 26 | 49 | 12 | $984 |
| Takhzyro Lanadelumab-Flyo | 25 | 25 | Under 11 | $953K |
| Fluticasone Propionate Generic | 22 | 31 | Under 11 | $214 |
| Xolair Omalizumab | 22 | 22 | Under 11 | $53K |
| Levocetirizine Dihydrochloride Generic | 16 | 24 | Under 11 | $97.5 |
| Spiriva Respimat Tiotropium Bromide | 16 | 17 | Under 11 | $9,271 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 16 | 28 | Under 11 | $18K |
| Azithromycin Generic | 14 | 14 | Under 11 | $75.77 |
| Firazyr Icatibant Acetate | 12 | 12 | Under 11 | $395K |
| Dupixent Pen Dupilumab | 12 | 12 | Under 11 | $44K |
Brand drugs: 190 claims; generic drugs: 236 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Madhurima Sanka $1,339 ($1,339 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $300.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $300 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $192 |
| CSL Behring CSL.AX | 10 | $187 |
| GlaxoSmithKline, LLC. GSK | 7 | $144 |
| Amgen Inc. AMGN | 4 | $140 |
| Genzyme Corporation SNY | 3 | $79.93 |
| Grifols USA, LLC | 2 | $48.33 |
| Pharming Healthcare, Inc. | 2 | $39.72 |
| BioCryst US Sales Co., LLC | 1 | $32.75 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $31.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.